REXAHN PHARMACEUTICALS INC 10-Q 3-31-2010

Company

Opus Genetics, Inc.

Filed

May 21, 2010

Period of Report

March 31, 2010

Accession Number

0001140361-10-022639

A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →